Page 52 - IJB-10-5

International Journal of Bioprinting Bioprinted tumor immune microenvironment

44. Zhou Y, Li M, Zhou K, et al. Engineering induced 57. Noy R, Pollard JW. Tumor-associated macrophages: from
pluripotent stem cells for cancer immunotherapy. Cancers. mechanisms to therapy. Immunity. 2014;41(1):49-61.
2022;14(9):2266. doi: 10.1016/j.immuni.2014.06.010
doi: 10.3390/cancers14092266
58. Lee KY, Mooney DJ. Alginate: properties and biomedical
45. Abraham RT, Weiss A. Jurkat T cells and development of applications. Prog Polym Sci. 2012;37(1):106-126.
the T-cell receptor signalling paradigm. Nat Rev Immunol. doi: 10.1016/j.progpolymsci.2011.06.003
2004;4(4):301-308. 59. Yang D, Jones KS. Effect of alginate on innate immune
doi: 10.1038/nri1330 activation of macrophages. J Biomed Mater Res.
46. Klingemann H, Boissel L, Toneguzzo F. Natural killer 2009;90(2):411-418.
cells for immunotherapy–advantages of the NK-92 doi: 10.1002/jbm.a.32096
cell line over blood NK cells. Front Immunol. 2016; 60. Alipal J, Pu’Ad NM, Lee T, et al. A review of gelatin: properties,
14(7):91. sources, process, applications, and commercialisation. Mater
doi: 10.3389/fimmu.2016.00091 Today: Proc. 2021;42(1):240-250.
47. Chanput W, Mes JJ, Wichers HJ. THP-1 cell line: an in doi: 10.1016/j.matpr.2020.12.922
vitro cell model for immune modulation approach. Int 61. Elalouf A. Immune response against the biomaterials used in
Immunopharmacol. 2014;23(1):37-45. 3D bioprinting of organs. Transpl Immunol. 2021;69:101446.
doi: 10.1016/j.intimp.2014.08.002 doi: 10.1016/j.trim.2021.101446
48. Gong J-H, Maki G, Klingemann HG. Characterization of a 62. Necas J, Bartosikova L, Brauner P, Kolar J. Hyaluronic acid
human cell line (NK-92) with phenotypical and functional (hyaluronan): a review. Vet Med. 2008;53(8):397-411.
characteristics of activated natural killer cells. Leukemia. doi: 10.17221/1930-VETMED
1994;8(4):652-658.
63. Haas A. The phagosome: compartment with a license to kill.
49. Laskowski TJ, Biederstadt A, Rezvani K. Natural killer Traffic. 2007;8(4):311-330.
cells in antitumour adoptive cell immunotherapy. Nat Rev doi: 10.1111/j.1600-0854.2006.00531.x
Cancer. 2022;22(10):557-575.
doi: 10.1038/s41568-022-00491-0 64. Johnson P, Ruffell B. CD44 and its role in inflammation
and inflammatory diseases. Inflamm Allergy Drug Targets.
50. Zhu H, Blum RH, Bjordahl R, et al. Pluripotent stem 2009;8(3):208-220.
cell-derived NK cells with high-affinity noncleavable doi: 10.2174/187152809788680994
CD16a mediate improved antitumor activity. Blood.
2020;135(6):399-410. 65. Assmann V, Fieber C, Herrlich P, et al. CD44 is the principal
doi: 10.1182/blood.2019000621 mediator of hyaluronic-acid-induced melanoma cell
proliferation. J Invest Dermatol. 2001;116(1):93-101.
51. Lu P, Weaver VM, Werb Z. The extracellular matrix: doi: 10.1046/j.1523-1747.2001.00236.x
a dynamic niche in cancer progression. J Cell Biol.
2012;196(4):395-406. 66. Avila Rodríguez MI, Rodríguez Barroso LG, Sánchez ML.
doi: 10.1083/jcb.201102147 Collagen: a review on its sources and potential cosmetic
applications. J Cosmet Dermatol. 2018;17(1):20-26.
52. Mai Z, Lin Y, Lin P, et al. Modulating extracellular doi: 10.1111/jocd.12450
matrix stiffness: a strategic approach to boost cancer
immunotherapy. Cell Death Dis. 2024;15(5):307. 67. Lynn A, Yannas I, Bonfield W. Antigenicity and
doi: 10.1038/s41419-024-06697-4 immunogenicity of collagen. J Biomed Mater Res B Appl
Biomater. 2004;71(2):343-354.
53. Park Y, Lee D, Lee JE, et al. The matrix stiffness coordinates doi: 10.1002/jbm.b.30096
the cell proliferation and PD-L1 expression via YAP in lung
adenocarcinoma. Cancers. 2024;16(3):598. 68. Kuczek DE, Larsen AMH, Thorseth M-L, et al. Collagen
doi: 10.3390/cancers16030598 density regulates the activity of tumor-infiltrating T cells. J
Immunother Cancer. 2019;7(1):68.
54. Hynes RO. The extracellular matrix: not just pretty fibrils. doi: 10.1186/s40425-019-0556-6
Science. 2009;326(5957):1216-1219.
doi: 10.1126/science.1176009 69. Kou SG, Peters LM, Mucalo MR. Chitosan: a review of
sources and preparation methods. Int J Biol Macromol.
55. Joyce JA, Fearon DT. T cell exclusion, immune privilege, 2021;169:85-94.
and the tumor microenvironment. Science. 2015; doi: 10.1016/j.ijbiomac.2020.12.005
348(6230):74-80. 70. Oliveira MI, Santos SG, Oliveira MJ, et al. Chitosan drives
doi: 10.1126/science.aaa6204
anti-inflammatory macrophage polarisation and pro-
56. Madsen CD, Sahai E. Cancer dissemination—lessons from inflammatory dendritic cell stimulation. Eur Cell Mater.
leukocytes. Dev Cell. 2010;19(1):13-26. 2012;24(136):133-136.
doi: 10.1016/j.devcel.2010.06.013 doi: 10.22203/ecm.v024a10

Volume 10 Issue 5 (2024) 44 doi: 10.36922/ijb.3988